BioSpace News Archive

Predictive biomarkers can reduce unnecessary treatment and adverse effects unlike chemotherapy and targeted therapies which may cause toxic effects.

The Janssen Pharmaceutical Companies of Johnson & Johnson is delighted with the recent announcement from the World Health Organisation (WHO) to include abiraterone acetate (ZYTIGA®) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), in the updated Essential Medicines List, published on 9th July 2019

Health Canada is aware that Pfizer Canada is reporting that a shortage of its 0.3 mg format EpiPen auto-injector may lead to temporary supply constraints in the coming months. EpiPen Jr (0.15 mg) is not affected by this shortage.

The NRP Group, a vertically-integrated, best-in-class developer, builder and manager of multifamily housing, today announced it will partner with The MetroHealth System and CCH Development Corp. to develop a mixed-use community in Cleveland’s Clark-Fulton neighborhood.

Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with oral ulcers associated with Behçet’s Disease.

The Global Healthy Living Foundation urges 2020 Presidential candidates to support the rescheduling of marijuana so that it, along with CBD products, can be tested under controlled parameters and with peer review to assess their safety, dosing, and effectiveness, arming both patients and doctors with the best available evidence to make informed treatment decisions

The first ever Medline-hosted Clinical Standardization Summit for recently combined Bon Secours Mercy Health drove $2.1 million in immediate savings for the organization, the system and Medline announced today.

Biohaven Pharmaceutical Holding Company Ltd. announced that it has received a Complete Response Letter from the FDA for the 5052 application seeking approval for NURTEC™ for ALS.

Austin Pathology Associates (“Austin Pathology”) has been informed by Retrieval Masters Creditors Bureau d/b/a American Medical Collection Agency (“AMCA”) of a data security incident involving the AMCA payment website.

Laboratory of Dermatopathology ADX, LLC (“LDA”), has been informed by Retrieval Masters Creditors Bureau d/b/a American Medical Collection Agency (“AMCA”) of a data security incident involving the AMCA payment website.